Generic Semaglutide Pricing Could Disrupt Global Markets
Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.
Pfizer Drug Pricing Deal Sees Stocks Soar
Learn about the Pfizer drug pricing deal that has stirred market reactions. Find out why analysts call it "more optics than bite".
Pharma Giants Sidelined in R15.5bn HIV Drug Tender
The recent R15.5 billion ARV tender sidelines Pharma Giants in South Africa, raising questions about local production support.
NUMSA Agreement Secures Pharmaceutical Worker Pay Increases
The National Union of Metalworkers of South Africa (Numsa) has successfully negotiated a two-year wage agreement with employers in the nation’s burgeoning pharmaceutical sector. This negotiation secures significant pay increases and improved benefits for approximately 10,000 workers…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
Trump’s Tariff Stick Won’t Bring Generic Drug Manufacturing Home
Analyze the implications of Trump's Tariff Stick for the US generics industry. Tariffs might worsen the supply of critical medicines.
Adcock Ingram’s Lenbucod Blocked by Court Ruling
Adcock Ingram's Lenbucod blocked by court order over trademark infringement with Aspen's Mybucod. Learn more about the battle.
Adcock Ingram’s Urizone Wins Trademark Battle
Adcock Ingram's Urizone receives legal protection as the court halts Cipla's Furizome, citing trademark infringement.
Pharmaceutical industry fights to shield drugs from tariffs
Pharmaceutical companies urge the Trump administration and EU to exclude medical goods from tariff wars, warning of potential price hikes and access barriers.
SAHPRA calls for Increased National Treasury funding
The SA Health Products Regulatory Authority (SAHPRA) has appealed to the National Treasury for more funding, warning of operational risks due to over-reliance on fee income.